Cosomil Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$6.45M
- Investors
-
9
Cosomil General Information
Description
Developer of a liquid-based diagnostic technology designed to offer early disease diagnosis and support for drug development. The company uses single enzyme activity-based protein profile technology, which detects enzyme activity with ultra-high sensitivity at the single molecule level using fluorescent probes and microdevices, enabling the medical system to provide early and accurate diagnosis of diseases, which can lead to improved patient outcomes.
Contact Information
Website
www.cosomil.comCorporate Office
- 604, Entrepreneur Plaza, University of Tokyo
- 7-3-1 Hongo, Bunkyo-ku
- Tokyo, 113-0033
- Japan
Corporate Office
- 604, Entrepreneur Plaza, University of Tokyo
- 7-3-1 Hongo, Bunkyo-ku
- Tokyo, 113-0033
- Japan
Cosomil Timeline
Cosomil Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC (Series A1) | 06-Feb-2026 | $6.45M | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 29-Nov-2023 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Dec-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | 25-Jul-2022 | Completed | Startup |
Cosomil Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class A2 | ||||||||
| Class A1 | ||||||||
| Class A | 69,635 | $55.01 | $55.01 | 1x | $55.01 | 24.6% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cosomil Signals
Cosomil Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Animal Spirits | Impact Investing | Minority | ||
| Delight Ventures | Venture Capital | Minority | ||
| Gogin Capital | PE/Buyout | Minority | ||
| Beyond Japan | Accelerator/Incubator | |||
| Coral Capital. | Venture Capital | Minority |
Cosomil FAQs
-
When was Cosomil founded?
Cosomil was founded in 2022.
-
Where is Cosomil headquartered?
Cosomil is headquartered in Tokyo, Japan.
-
What is the size of Cosomil?
Cosomil has 27 total employees.
-
What industry is Cosomil in?
Cosomil’s primary industry is Biotechnology.
-
Is Cosomil a private or public company?
Cosomil is a Private company.
-
What is the current valuation of Cosomil?
The current valuation of Cosomil is .
-
What is Cosomil’s current revenue?
The current revenue for Cosomil is .
-
How much funding has Cosomil raised over time?
Cosomil has raised $6.45M.
-
Who are Cosomil’s investors?
Animal Spirits, Delight Ventures, Gogin Capital, Beyond Japan, and Coral Capital. are 5 of 9 investors who have invested in Cosomil.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process